A Pre-Approval Information Exchange (PIE) Webinar, sponsored by Syndax Pharmaceuticals.

Pre-Approval Information Exchange (PIE) presentation for investigational revumenib, including a clinical overview, burden of disease, and disease background for pediatric and adult patients harboring KMT2A-rearranged relapsed or refractory acute leukemia.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

The AMCP Format for Formulary Submissions (the Format) defines the best practice for pharmaceutical manufacturer dossiers. In April 2024, AMCP released Format version 5.0, the first update to the Format since 2020. In this educational session, two individuals who contributed to the update will provide details of the new and improved Format v5.0.

An AMCP Webinar, hosted by FormularyDecisions^®.

Please join us for an interactive, engaging, and informative discussion to discover the keys to thriving in the dynamic biosimilars landscape. In this interactive session, you will gain practical insights on navigating regulatory challenges, seizing opportunities for collaboration, and communicating effectively with stakeholders.

Stay ahead of the curve with up-to-date industry trends and expert strategies tailored to driving success in the U.S. biosimilars market. Register today to secure your spot!

Open to AMCP Members Only

This webinar will provide an overview for AMCP Members considering future Board Service. Join this session to learn the information you need to prepare, including Board responsibilities, expectations, AMCP's commitment to diversity and inclusion, the Leadership Development committee selection process, and information on AMCP's Entities: AMCP Foundation, AMCP Research Institute and BBCIC, Committees, and AMCP's Strategic and Policy Priorities.

An AMCP CPE Webinar.

Breast cancer stands as one of the leading forms of cancer nationwide, affecting thousands of people every year. Behind this statistic lie complex health disparities that significantly influence treatment outcomes, particularly among marginalized groups.

This session will explore the latest advancements in breast cancer management and analyze the intersection of gender and health disparities that contribute to health outcomes. Additionally, it will explore different managed care strategies to improve equitable access to treatment for vulnerable populations.

This activity is supported by an independent medical education grant from Merck and Novartis.